Affordable Access

deepdyve-link
Publisher Website

Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab.

Authors
  • Kim, Jae Hui1
  • Chang, Young Suk2
  • Kim, Jong Woo1
  • Kim, Chul Gu1
  • Lee, Dong Won1
  • 1 1 Department of Ophthalmology, Kim's Eye Hospital, Konyang University College of Medicine , Seoul, South Korea . , (North Korea)
  • 2 2 Department of Ophthalmology, Konyang University College of Medicine , Daejeon, South Korea . , (North Korea)
Type
Published Article
Journal
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Publication Date
Sep 01, 2016
Volume
32
Issue
7
Pages
431–436
Identifiers
DOI: 10.1089/jop.2016.0066
PMID: 27479572
Source
Medline
License
Unknown

Abstract

The long-term outcome of intravitreal bevacizumab treatment for idiopathic CNV was generally favorable. Although CNV recurrence was noted in 30.8% of patients, the recurrence may not significantly influence long-term visual prognosis.

Report this publication

Statistics

Seen <100 times